Repaglinida (Prandin in the U.S. , GlucoNorm en Canadá, NovoNorm Hypover) es un agente antidiabético diabetes de tipo 2 comercializado por Novo Nordisk. La repaglinida viene en tabletas de 0.5 mg, 1 mg y 2 mg. Repaglinida pertenece a la clase de meglitinidas de hipoglicemiantes.
Bioavailability |
|
C |
|
Chem Spider ID |
|
rdfs:comment |
|
foaf:depiction | |
Drug Bank |
|
Excreción |
|
H |
|
Imagen |
|
In Ch I |
|
In Ch IKey |
|
foaf:isPrimaryTopicOf | |
rdfs:label |
|
Legal UK |
|
Legal US |
|
Licence EU |
|
Licence US |
|
Metabolismo |
|
Molecular Weight |
|
N |
|
Nombre IUPAC |
|
Número CAS |
|
O |
|
Prefijo ATC |
|
Pregnancy Category |
|
Is foaf:primaryTopic of | |
Protein Bound |
|
Pub Chem |
|
Routes Of Administration |
|
SMILES |
|
dcterms:subject | |
Sufijo ATC |
|
dbpedia-owl:thumbnail | |
UNII |
|
Verifiedrevid |
|
Vida Media |
|
prov:wasDerivedFrom | |
dbpedia-owl:wikiPageID |
|
dbpedia-owl:wikiPageLength |
|
dbpedia-owl:wikiPageOutDegree |
|
dbpedia-owl:wikiPageRevisionID |
|
prop-latam:wikiPageUsesTemplate | |
dbpedia-owl:wikiPageWikiLink | [11 values] |
Is dbpedia-owl:wikiPageWikiLink of |